Irregularities in the manufacturing process were detected, leading to possible insufficient filling of the last 50 oral applicators of the Rotarix batch, meaning failure to meet quality requirements for the volume parameter. Potential effects: lack of vaccination efficacy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use product from batch AROLC214AE; patients and caregivers should check the batch number, return the product to the pharmacy or doctor, and consult a physician about the need for re-vaccination...
The Chief Pharmaceutical Inspector decided to withdraw the medicinal product Rotarix batch AROLC214AE from the market throughout the country and granted the decision immediate enforceability; the mark...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related